newsfilter
← Latest News
GlobeNewswire·

Achilles Therapeutics to Present at Upcoming Conferences

LONDON, June 12, 2023 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ:ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced that